Cited by

• Cholangiocarcinoma: modern advances in understanding a deadly old disease.

  Malhi H, Gores GJ. Malhi H, et al. J Hepatol. 2006 Dec;45(6):856-67. doi: 10.1016/j.jhep.2006.09.001. Epub 2006 Sep 25. J Hepatol. 2006. PMID: 17030071 Free PMC article. Review.
• ACOT12-mediated acetyl-CoA hydrolysis suppresses intrahepatic cholangiocarcinoma metastasis by inhibiting epithelial-mesenchymal transition.

  Zhou X, Zhou Y, Shao W, Hong L, Lu M, Zhu W. Zhou X, et al. J Cancer. 2022 Mar 14;13(6):1734-1744. doi: 10.7150/jca.62169. eCollection 2022. J Cancer. 2022. PMID: 35399720 Free PMC article.
• Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma.

  Cheng J, Mao Y, Hong W, Hu W, Shu P, Huang K, Yu J, Jiang M, Li L, Wang W, Ni D, Li S. Cheng J, et al. J Transl Med. 2022 Jun 15;20(1):272. doi: 10.1186/s12967-022-03473-w. J Transl Med. 2022. PMID: 35705951 Free PMC article.
• Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study.

  de Sio I, Iadevaia MD, Vitale LM, Niosi M, Del Prete A, de Sio C, Romano L, Funaro A, Meucci R, Federico A, Loguercio C, Romano M. de Sio I, et al. United European Gastroenterol J. 2014 Aug;2(4):279-87. doi: 10.1177/2050640614538964. United European Gastroenterol J. 2014. PMID: 25083285 Free PMC article.
• Liver fluke induces cholangiocarcinoma.

  Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana S, Thinkamrop B, Bethony JM, Loukas A, Brindley PJ. Sripa B, et al. PLoS Med. 2007 Jul;4(7):e201. doi: 10.1371/journal.pmed.0040201. PLoS Med. 2007. PMID: 17622191 Free PMC article. Review.